DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 121 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2015. The put-call ratio across all filers is 0.06 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $5,961,000 | +91.4% | 277,288 | -14.1% | 0.48% | +146.4% |
| Q2 2017 | $3,114,000 | +29.3% | 322,746 | -20.3% | 0.20% | +5.4% |
| Q1 2017 | $2,409,000 | +46.6% | 404,930 | -2.6% | 0.19% | +60.3% |
| Q4 2016 | $1,643,000 | -82.8% | 415,893 | -54.4% | 0.12% | -79.8% |
| Q3 2016 | $9,561,000 | -49.1% | 911,326 | -29.3% | 0.57% | -57.7% |
| Q2 2016 | $18,791,000 | -16.6% | 1,288,771 | +10.1% | 1.36% | -0.6% |
| Q1 2016 | $22,520,000 | +90.6% | 1,170,440 | +139.3% | 1.37% | +55.8% |
| Q4 2015 | $11,815,000 | +8.9% | 489,050 | +10.6% | 0.88% | +3.2% |
| Q3 2015 | $10,848,000 | +9.0% | 442,065 | +4.0% | 0.85% | +21.1% |
| Q2 2015 | $9,953,000 | – | 424,907 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 10,895,773 | $47,070,000 | 4.39% |
| DC Investments Management, LLC | 196,799 | $850,000 | 0.93% |
| Chicago Capital, LLC | 3,930,524 | $16,980,000 | 0.87% |
| PFM Health Sciences, LP | 2,936,990 | $12,688,000 | 0.59% |
| Avidity Partners Management LP | 2,025,000 | $8,748,000 | 0.41% |
| Soleus Capital Management, L.P. | 167,798 | $725,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 925,534 | $3,998,000 | 0.36% |
| Haafor (Singapore) Pte. Ltd. | 27,128 | $117,000 | 0.24% |
| JACKSON SQUARE CAPITAL, LLC | 122,555 | $529,000 | 0.23% |
| Parkman Healthcare Partners LLC | 200,000 | $864,000 | 0.23% |